Different Etiological Entities of Liver Cancer Across Populations: Implications From Age-Period-Cohort Analysis on Incidence Trends

被引:0
作者
Chen, Tian-Wen [1 ]
Cheng, Yi-Jun [1 ]
Huang, Yong-Ying [2 ]
Liu, Zhiqiang [1 ]
Liu, Jing-Feng [2 ]
Xie, Shao-Hua [1 ,3 ,4 ]
机构
[1] Fujian Med Univ, Sch Publ Hlth, Fuzhou, Peoples R China
[2] Fujian Med Univ, Fujian Canc Hosp, Clin Oncol Sch, Fuzhou, Peoples R China
[3] Fujian Med Univ, Inst Populat Med, Fuzhou, Peoples R China
[4] Karolinska Inst, Dept Mol Med & Surg, Upper Gastrointestinal Surg, Stockholm, Sweden
关键词
liver cancer; epidemiology; time trends; age-period-cohort analysis; C VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; RISK-FACTORS; ATTRIBUTABLE FRACTIONS; CHANGING EPIDEMIOLOGY; UNITED-STATES; BURDEN; MODELS;
D O I
10.14309/ctg.0000000000000769
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
INTRODUCTION:The incidence of liver cancer has shown different temporal trends across populations, while the underlying reasons remain unclear.METHODS:We examined temporal trends in the incidence of liver cancer in Hong Kong, Sweden, and the United States since the 1970s through 2021 using joinpoint regression and age-period-cohort analysis.RESULTS:The age-standardized incidence rate of liver cancer in Hong Kong steadily decreased (average annual percentage change [AAPC] -2.2%, 95% confidence interval [CI] -2.8% to -1.7% in men; AAPC -2.1%, 95% CI -3.1% to -1.1% in women) in 1983-2020. The rate in Sweden increased on average by 0.8% (95% CI 0.2%-1.4%) per year in men and was stable in women (AAPC 0.2%, 95% CI -0.9%-1.4%) in 1970-2021. The rate in the United States increased by 2.1% (95% CI 1.5%-2.8%) per year in men and by 2.1% (95% CI 1.6%-2.5%) in women in 1975-2020, but decreasing trends were noted in 2015-2020 (AAPC -6.6%, 95% CI -8.3% to -4.9% in men; AAPC -4.2%, 95% CI -7.5% to -0.8% in women). Stratified analysis by histological type showed such decrease in recent years was limited to hepatocellular carcinoma, rather than intrahepatic cholangiocarcinoma. We observed distinct changes in trends across age groups and different trends across birth cohorts.DISCUSSION:The incidence of liver cancer has decreased in Hong Kong but increased in Sweden and in the United States since the 1980s, despite the decreasing incidence in the United States since 2015. Such disparities may be explained by different etiology and implementation of preventive measures across populations.
引用
收藏
页数:10
相关论文
共 34 条
[1]   Racial/ethnic disparities in hepatocellular carcinoma incidence and mortality rates in the United States, 1992-2018 [J].
Alvarez, Christian S. ;
Petrick, Jessica L. ;
Parisi, Dominick ;
McMahon, Brian J. ;
Graubard, Barry, I ;
McGlynn, Katherine A. .
HEPATOLOGY, 2022, 76 (03) :589-598
[2]   The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States [J].
Armstrong, GL ;
Alter, MJ ;
McQuillan, GM ;
Margolis, HS .
HEPATOLOGY, 2000, 31 (03) :777-782
[3]  
Baecker A, 2018, EUR J CANCER PREV, V27, P205, DOI [10.1097/cej.0000000000000428, 10.1097/CEJ.0000000000000428]
[4]   Hepatitis C Virus Infection and the Temporal Trends in the Risk of Liver Cancer: A National Register-Based Cohort Study in Sweden [J].
Batyrbekova, Nurgul ;
Aleman, Soo ;
Lybeck, Charlotte ;
Montgomery, Scott ;
Duberg, Ann-Sofi .
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2020, 29 (01) :63-70
[5]   The Hong Kong consensus statements on unresectable hepatocellular carcinoma: narrative review and update for 2021 [J].
Cheung, Tan-To ;
Yu, Simon Chun-Ho ;
Chan, Stephen L. ;
Poon, Ronnie T. P. ;
Kwok, Philip ;
Lee, Ann-Shing ;
Tai, Anna ;
Tam, Derek ;
Cheung, Chin-Cheung ;
Lai, Tak-Wing ;
Chia, Nam-Hung ;
Law, Ada ;
Shum, Tracy ;
Lam, Yim-Kwan ;
Lau, Vince ;
Lee, Victor ;
Chong, Charing ;
Tang, Chung-Ngai ;
Yau, Thomas .
HEPATOBILIARY SURGERY AND NUTRITION, 2023, 12 (03) :366-385
[6]   An overview in management of hepatocellular carcinoma in Hong Kong using the Hong Kong Liver Cancer (HKLC) staging system [J].
Chui, Arnold Man Nok ;
Yau, Thomas Chung Cheung ;
Cheung, Tan To .
GLOBAL HEALTH & MEDICINE, 2020, 2 (05) :312-318
[7]   The changing epidemiology of hepatitis C virus infection in the United States: National health and nutrition examination survey 2001 through 2010 [J].
Ditah, Ivo ;
Ditah, Fausta ;
Devaki, Pardha ;
Ewelukwa, Oforbuike ;
Ditah, Chobufo ;
Njei, Basile ;
Luma, Henry N. ;
Charlton, Michael .
JOURNAL OF HEPATOLOGY, 2014, 60 (04) :691-698
[8]   The European cancer burden in 2020: Incidence and mortality estimates for 40 countries and 25 major cancers [J].
Dyba, Tadeusz ;
Randi, Giorgia ;
Bray, Freddie ;
Martos, Carmen ;
Giusti, Francesco ;
Nicholson, Nicholas ;
Gavin, Anna ;
Flego, Manuela ;
Neamtiu, Luciana ;
Dimitrova, Nadya ;
Carvalho, Raquel Negrao ;
Ferlay, Jacques ;
Bettio, Manola .
EUROPEAN JOURNAL OF CANCER, 2021, 157 :308-347
[9]   Epidemiology and risk factors: intrahepatic cholangiocarcinoma [J].
Gupta, Amar ;
Dixon, Elijah .
HEPATOBILIARY SURGERY AND NUTRITION, 2017, 6 (02) :101-104
[10]   Long-term incidence in hepatocellular carcinoma and intrahepatic bile duct cancer in Denmark, Finland, Norway and Sweden, role of Thorotrast? [J].
Hemminki, Kari ;
Tichanek, Filip ;
Foersti, Asta ;
Hemminki, Otto ;
Liska, Vaclav ;
Hemminki, Akseli .
INTERNATIONAL JOURNAL OF CANCER, 2022, 151 (04) :510-517